BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 114751)

  • 1. An assay for the quantitative inhibition of anti-immunoglobulin antibodies performed at the cell surface. Studies with anti-kappa and anti-mu chain antibodies.
    Stanislawski M; Mitard M; Harel A
    Mol Immunol; 1979 May; 16(5):317-26. PubMed ID: 114751
    [No Abstract]   [Full Text] [Related]  

  • 2. Derivation and diversification of monoclonal antibodies.
    Köhler G
    Science; 1986 Sep; 233(4770):1281-6. PubMed ID: 3092353
    [No Abstract]   [Full Text] [Related]  

  • 3. The structural basis of antigenic determinants on V kappa 21 light chains.
    Julius MA; McKean DJ; Potter M; Feldmann RJ; Weigert M
    Mol Immunol; 1981 Jan; 18(1):1-9. PubMed ID: 6167848
    [No Abstract]   [Full Text] [Related]  

  • 4. The antigen-binding domain of a human IgG-anti-F(ab')2 autoantibody.
    Welschof M; Terness P; Kipriyanov SM; Stanescu D; Breitling F; Dörsam H; Dübel S; Little M; Opelz G
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1902-7. PubMed ID: 9050877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal antibodies against human anti-F(ab')2 antibodies react with light chain epitopes.
    Silvestris F; Rots N; Yancey WB; Malone C; Searles R; Solomon A; Dammacco F; Williams RC
    Clin Immunol Immunopathol; 1991 Apr; 59(1):139-55. PubMed ID: 1708314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogenic effect on human lymphocytes of insolubilized anti-immunoglobulins. I. Specificity of the stimulating agent.
    Henriksen A; Godal T; Landaas TO
    J Immunol; 1980 Feb; 124(2):921-5. PubMed ID: 6766166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of monoclonal anti-mouse immunoglobulin to detect mouse antibodies.
    Yelton DE; Desaymard C; Scharff MD
    Hybridoma; 1981; 1(1):5-11. PubMed ID: 6821395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of antibody and helper T-cell responses to the isologous myeloma protein W3129 and its subunits.
    Bogen B; Hannestad K
    Mol Immunol; 1984 Jul; 21(7):653-61. PubMed ID: 6205254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of 'single shot' intrasplenic immunization for production of monoclonal antibodies specific for human IgM.
    Gearing AJ; Thorpe R; Spitz L; Spitz M
    J Immunol Methods; 1985 Feb; 76(2):337-43. PubMed ID: 3919104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of human B cells and inhibition of their terminal differentiation by monoclonal anti-mu antibodies.
    Maruyama S; Kubagawa H; Cooper MD
    J Immunol; 1985 Jul; 135(1):192-9. PubMed ID: 3923101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies specific for rat IgG1, IgG2a, and IgG2b subclasses, and kappa chain monotypic and allotypic determinants: reagents for use with rat monoclonal antibodies.
    Springer TA; Bhattacharya A; Cardoza JT; Sanchez-Madrid F
    Hybridoma; 1982; 1(3):257-73. PubMed ID: 6208128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiotypic specificities of rabbit antibodies to immunoglobulin allotypes.
    Gilman-Sachs A; Dray S; Horng WJ
    J Immunol; 1982 Sep; 129(3):1194-9. PubMed ID: 6179997
    [No Abstract]   [Full Text] [Related]  

  • 13. Properties of monoclonal antibodies to human immunoglobulin kappa and lambda chains.
    Lowe J; Hardie D; Jefferis R; Ling NR; Drysdale P; Richardson P; Raykundalia C; Catty D; Appleby P; Drew R; Maclennan IC
    Immunology; 1981 Apr; 42(4):649-59. PubMed ID: 6786981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human anti-F(ab')2 antibodies and pepsin agglutinators react with Fv determinants.
    Silvestris F; Williams RC; Searles RP
    Scand J Immunol; 1986 Apr; 23(4):499-508. PubMed ID: 2422740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of immunoglobulin-related molecules on human peripheral blood T lymphocytes using chicken anti-F(ab')2 and anti-IgM antibodies.
    Haegert DG
    Immunology; 1980 Nov; 41(3):663-71. PubMed ID: 6161876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of a monoclonal anti-mu chain antiserum on the in vitro growth of normal B cells.
    Boyd AW; Pike BL
    Eur J Immunol; 1982 Mar; 12(3):184-8. PubMed ID: 6807696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of antigen-specific immunological memory through variable regions of heavy and light chains of anti-idiotypic antibody.
    Vani J; Nayak R; Shaila MS
    Immunology; 2007 Apr; 120(4):486-96. PubMed ID: 17229267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of idiotype variants during treatment of B-cell lymphoma with anti-idiotype antibodies.
    Meeker T; Lowder J; Cleary ML; Stewart S; Warnke R; Sklar J; Levy R
    N Engl J Med; 1985 Jun; 312(26):1658-65. PubMed ID: 3923352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of kappa chains of the V kappa 21 group in Mus musculus and related species.
    Julius MA; McKean DJ; Potter M; Weigert M
    Mol Immunol; 1981 Jan; 18(1):11-7. PubMed ID: 6167849
    [No Abstract]   [Full Text] [Related]  

  • 20. The immunoglobulin-like T cell receptor--IV. Quantitative cellular assay and partial characterization of a heavy chain cross-reactive with the Fd fragment of serum mu chain.
    Marchalonis JJ; Warr GW; Santucci LA; Szenberg A; von Fellenberg R; Burckhardt JJ
    Mol Immunol; 1980 Jul; 17(7):985-99. PubMed ID: 6163977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.